OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-06-30-accounts

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

Laboratory Animal Science Association

Unaudited Financial Statements For the year ended 30 June 2025

Company Number: 08707797 (England & Wales) Charity Number: 1164804

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION

CONTENTS

----- Start of picture text -----
Page
Reference and Administrative Details 1
Report of the Board of Trustees 2 to 6
Independent Examiner's report 7
Statement of Financial Activities 8
Balance Sheet 9
Notes to the Financial Statements 10 to 14
----- End of picture text -----

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION

Reference and Administrative Details For the year ended 30 June 2025

Company Number: 08707797 Charity Number: 1164804 Registered Office: 6th Floor 9 Appold Street London, England EC2A 2AP Directors and Trustees: Dr Jordi Lopez Tremoleda Dr Sally Robinson Dr Sara Elizabeth Wells (appointed 1 January 2025) Dr Susan Clare Stanford (resigned 1 January 2025) Dr Jill Reckless (resigned 1 January 2025) Independent examiner Moore Kingston Smith LLP 6th Floor 9 Appold Street London EC2A 2AP

1

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION Trustees’ Annual Report For the year ended 30 June 2025

The trustees of Laboratory Animal Science Association (“LASA”), who are also directors of the charitable company for the purposes of the Companies Act 2006, present their report together with the financial statements for the year ended 30 June 2025. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommend Practice applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102).

Structure, Governance and Management

LASA is a charitable company governed by its Memorandum and Articles of Association.

LASA is run by an Executive Committee comprising the three trustees of the charity plus the treasurer, supported by a team of elected members, who collectively comprise LASA Council.

New trustees must be nominated (and seconded) by any two members of LASA, with subsequent election at the Annual General Meeting. Currently, there are three trustees, one of whom (Chair of the Scientific Committee) will be standing down at the end of the year. One new trustee will be elected at the AGM in November 2025 to fulfil this role.

LASA occasionally collaborates with other organisations for example: the Institute of Animal Technicians, Royal Society for the Protection of Animals, Laboratory Animal Veterinary Association, National Centre for the Replacement, Refinement and Reduction of Animal Research (NC3Rs), UK Biosciences Sector Coalition, Federation of Laboratory Animals Science Associations and Understanding Animal Research. However, these activities are project-driven and have no financial implications or obligations.

Some members of LASA Council are also members of other organisations, which helps to promote these collaborations and common interests. Arising from those relationships, all members of Council are required to provide a signed Declaration of Interests on their election as trustee or member of Council. LASA requires both trustees and council members to update this information annually.

Objective and Activities

The objects of the charitable company are to promote the advancement of laboratory animal science for the benefit of the public.

In furtherance of this object, but not otherwise:

The charitable company’s main activities in relations to those objects are:

This is achieved through:

2

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION Trustees’ Annual Report For the year ended 30 June 2025

The trustees have regard to the Charity Commission’s guidance on public benefit when reviewing their aims and objectives and in planning future activities.

All LASA’s Officers hold honorary posts and all LASA’s activities depend entirely on the voluntary efforts of its members. Such activities include, but are not limited to:

Achievements and Performance

The LASA Annual Meeting 2024 was successfully delivered and achieved its objectives of promoting best practices in laboratory animal science and welfare. The event was organized with the support of LASA members, Council, Executive Committee, Section Convenors, trade partners, and the RSB Events Team. Feedback from attendees confirmed the value of the scientific content, networking opportunities, and overall organization.

The meeting adopted a new format consisting of two half-day sessions and one full day, which improved accessibility and logistics for participants. Returning to a previous venue ensured highquality hosting and catering services, which were widely praised by attendees (over 200 attendees).

The scientific program was multidisciplinary and included sessions on species-specific welfare for fish, rodents and farm animals, as well as discussions on affective states, aging, staff training, and strategies for fostering interdisciplinary collaboration. Keynote presentations were delivered by Professor Stuart Peirson from the University of Oxford, Dr. Fiona Sewell from NC3Rs, and Professor Karen Blyth from the CRUK Scotland Institute. Additional contributions came from leading experts in animal welfare and research, further enriching the program.

Training and special sessions were also a key feature of the meeting. Establishment Licence Holder (PELH) training sessions were well attended and supported by ASPU and ASRU. Other sessions focused on animal sentience and innovation in animal science and the 3Rs, with the latter supported by NC3Rs.

Recognition was given to outstanding contributions during the event. Dr. Stuart Ainsworth received the award for best talk for his presentation on a substantially refined pre-clinical murine model for coagulopathic snakebite envenoming, an award supported by the Animals in Science Education Trust. Dr Cat Beatty won the best poster award, sponsored by Envigo/Inotiv, for her work on developing a monitoring and treatment regimen for NSG mice displaying phenotypic tarsal joint swelling and hock lesions.

Trade partners played an integral role in the success of the meeting, providing excellent exhibits and creating vibrant networking opportunities that added significant value to the event. LASA extends its sincere thanks to all contributors for their commitment to advancing animal welfare, science, and the principles of the 3Rs.

3

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION Trustees’ Annual Report For the year ended 30 June 2025

Our next Annual meeting, a core feature of our activities , will be held in November 2025. The LASA Annual Meeting 2025 will focus on the theme Modelling Biology and Its Impact on Science and Welfare. The event is designed to showcase a diverse range of species, technologies, and advanced animal models, emphasizing the role of animal research in driving scientific progress while maintaining the highest standards of animal welfare.

The PELh Section held their annual Establishment Licence Holders’ Forum in October 2024. This focused on the theme ‘Supporting Your Named Persons’. The meeting was instrumental to continue to support the regulated establishments across the UK. Speakers included members of the LAS community, members of the Home Office Animal Science Regulatory and Policy units, with over 80 attendees

Other key activities include:

A major development for LASA was the change in arrangements for the Secretariat: for many years, this had been outsourced to Agenda Resource Management but, since 1st January 2024, is now provided by the staff at the Royal Society for Biology. This change has offered an opportunity for LASA and the Secretariat to review and refine some operating procedures and activities.

A Review of LASA SECTIONs.

In 2024 we made several changes to the sections (highlighted in last year’s report). In 2025 we have considered how the sections can be more effective and have appointed a new council role to coordinate the sections and their work. As a reminder our sections are

DOPS . LASA hosts over 250 DOPS (Direct Observation of Procedural Skills) supplied by several organisations. We have decided to review our approach to DOPS and have currently removed access to these from the LASA Website. This decision is based on LASA’s resources, costs and governance processes.

Financial Review

LASA’s end-of-year balance stands at £258,052, continuing the improvement reported last year despite a sizeable decrease in total income to £158,743 (2024: £210,512).

A larger proportion of income this year was derived from members’ subscriptions (£29,271, up from £16,509), placing the charity in the desirable position that a greater share of administrative costs is now covered by membership fees.

The improved year-end balance, in the face of reduced total income, reflects the reduction in overall expenditure from £150,223 to £128,378. The primary contributor to this saving was lower meetingrelated expenditure, which fell from £95,935 to £77,915.

Administrative costs rose modestly (£28,243, up from £25,772), reflecting ongoing work to bring bookkeeping in-house and the higher service charges from the Royal Society of Biology (RSB). While these costs remain above historical levels, the move has the potential to improve transparency and efficiency in our financial management.

For 2025/26, we will continue to work closely with RSB to review the value provided, identify potential savings, and ensure that LASA’s administrative expenditure remains proportionate to the organisation’s income and activity levels.

4

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION Trustees’ Annual Report For the year ended 30 June 2025

The overall net surplus for the year was £30,365, enabling LASA to further strengthen its reserves and maintain a sound financial position going forward.

LASA reviewed and awarded six bursaries in this financial year. Four of these supported attendance at the FELASA Congress in June 2025 and so will not have been expensed back in this financial year. The remaining two were for members to attend scientific meetings (Society for Neuroscience conference 2024 and a prosocial workshop at University International of Andalucia respectively).

Reserves Policy

At the close of the financial year, LASA’s provisional unrestricted reserves stood at £85,766, representing approximately two-thirds of annual expenditure. This reflects a modest increase from the previous year (£84,999) and continues the positive trend of gradual reserve strengthening.

The trustees maintain a policy of holding sufficient unrestricted reserves to:

The trustees’ medium-term objective is to maintain unrestricted reserves equivalent to at least one year’s operating expenditure, with an aspirational long-term target of two years’ expenditure as a prudent safeguard against fluctuations in meeting income, sponsorship, and membership subscriptions.

The current reserves level is considered adequate but below the desired target. The trustees will continue to monitor the reserves position closely as part of LASA’s financial planning and risk management processes, with the aim of achieving the target level within the next three years through careful expenditure control and sustainable income generation.

Risk Management

The trustees recognise that effective risk management is essential to the charity’s governance and long-term sustainability. LASA maintains a Risk Register that is reviewed regularly by Council, with updates discussed whenever significant operational or financial changes occur. The register is used to identify, evaluate, and monitor potential threats to the charity’s activities, reputation, and financial stability, and to ensure appropriate mitigation strategies are in place.

During 2024/25, particular attention was given to risks arising from the transition of financial management to the Royal Society of Biology and from changes within the Executive team. The Honorary Treasurer role was transferred to a new appointee at the start of the financial year, with the previous Treasurer retained in a new VP position as Academic Liaison Lead to support continuity and maintain close engagement with the academic sector. The former President-Elect has also been retained as VP Biotech Liaison, helping to strengthen LASA’s external partnerships and diversification of funding sources. These positions are appointments of the LASA President as per the bylaws.

The trustees consider the principal risks currently facing LASA to be:

5

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION Trustees’ Annual Report For the year ended 30 June 2025

Mitigation measures include:

The trustees remain confident that the controls and monitoring processes in place are proportionate and effective, and that LASA is well positioned to continue delivering its charitable objectives within a managed risk framework.

Statement of responsibilities of the Trustees

The Trustees (who are also directors of the charity for the purposes of company law) are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102: The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charity and of the income and expenditure of the charity for that period. In preparing those financial statements the Trustees are required to:

The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charity and which enable them to ensure that the financial statements comply with the Companies Act 2006. The Trustees are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

This report was approved by the trustees on ….............................. and was signed on its behalf by: 17 December 2025

Dr S Robinson – Trustee and Honorary Secretary

6

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION

Independent Examiner's Report For the year ended 30 June 2025

I report to the charity trustees on my examination of the accounts of the Company for the year ended 30 June 2025.

Responsibilities and basis of report

As the charity’s trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.

Independent Examiner's Statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Adam Fullerton (FCA, DChA)

For and on behalf of Moore Kingston Smith LLP Chartered Accountants

6th Floor, 9 Appold Street London EC2A 2AP

Date: 17 December 2025

7

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION

Statement of Financial Activities For the year ended 30 June 2025

----- Start of picture text -----
Unrestricted funds
Notes 2025 2024
£ £
Income from:
Donations & legacies 63,368 37,225
Charitable activities 2 94,597 172,740
Investments 3 778 547
Total 158,743 210,512
Expenditure on:
Charitable activities 4 128,378 150,223
Total 128,378 150,223
Net income 30,365 60,289
NET MOVEMENT IN FUNDS 30,365 60,289
Reconciliation of funds:
Fund balance brought forward at 1 July 227,687 167,398
2024
Fund balance carried forward at 30
June 2025 11 258,052 227,687
----- End of picture text -----

The Statement of Financial Activities includes all gains and losses in the year and therefore a statement of recognised gains and losses has not been prepared.

All of the above amounts relate to continuing activities.

The notes on pages 10 to 14 form part of these financial statements.

8

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION

Balance Sheet

as at 30 June 2025

----- Start of picture text -----
Notes 2025 2024
£ £ £ £
CURRENT ASSETS
Debtors 9 6,561 64,968
Cash at bank and in hand 318,793 259,186
325,354 324,154
LIABILITIES
Creditors: Amounts falling due
within one year 10 (67,302) (96,467)
NET CURRENT ASSETS 258,052 227,687
TOTAL ASSETS LESS CURRENT LIABILITIES 258,052 227,687
FUNDS
Unrestricted funds 11 258,052 227,687
TOTAL FUNDS 258,052 227,687
----- End of picture text -----

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibility for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the special provisions for small companies under Part 15 of the Companies Act 2006.

These financial statements were approved by the members of the Trustee Board on 17 December 2025 and signed on their behalf by:

...................................................... Dr Sara Elizabeth Wells President - Trustee

Charity No. 1164804 Company No. 08707797 (England & Wales)

The notes on pages 10 to 14 form part of these financial statements.

9

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION

Notes to the accounts

For the year ended 30 June 2025

1 ACCOUNTING POLICIES

1.1 Company Information

Laboratory Animal Science Association is a private company limited by guarantee incorporated in England and Wales. The registered office is 6th Floor 9 Appold Street, London, England, EC2A 2AP.

1.2 Basis of Preparation

A summary of the principal accounting policies adopted, judgements and key sources of estimation uncertainty, is set out below.

The financial statements have been prepared in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). The company is a public benefit entity for the purposes of FRS 102 and a registered charity established as a company limited by guarantee and therefore has also prepared its financial statements in accordance with the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (The FRS 102 Charities SORP), the Companies Act 2006 and Charities Act 2011.

The financial statements are prepared in sterling, which is the functional currency of the association. Monetary amounts in these financial statements are rounded to the nearest pound.

The financial statements are prepared on the historical cost convention. The principal accounting policies adopted are set out below.

1.3 Going Concern

The trustees have assessed whether the use of going concern is appropriate and have considered possible events or conditions that might cast significant doubt on the ability of the charity to continue as a going concern. The trustees have made this assessment for a period of at least one year from the date of approval of these financial statements. In particular, the trustees have considered the charity's forecasts and projections and have taken account of pressures on income. After making enquiries, the trustees have concluded that there is a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. The charity therefore continues to adopt the going concern basis in preparing its financial statements.

1.4 Incoming resources

All incoming resources are recognised when the charity is entitled to the income, there is certainty of receipt and the monetary value can be measured with reasonable accuracy.

Members subscriptions are recognised as income in the period to which they are received, and any relating to future periods are treated as deferred income in the Balance Sheet.

1.5 Resources expended

Expenditure is included in the Statement of Financial Activities on an accruals basis. Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefit will be required in settlement and the amount of the obligation can be measured reliably.

1.6 Allocation and apportionment of costs

All costs are allocated between the expenditure categories of the SOFA on a basis designated to reflect the use of the resources. Cost relating to a particular activity are allocated directly and others are apportioned on an appropriate basis.

1.7 Fixed assets

Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less estimated residual value, over the expected useful life on the following basis:

10

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION

Notes to the accounts

For the year ended 30 June 2025

1.8 Taxation

The charitable company is an exempt charity within the meaning of Schedule 3 of the Charities Act 2011 and is considered to pass the test set out in Paragraph 1 Schedule 6 Finance Act 2010 therefore it meets the definition of a charitable company for UK tax purposes.

1.9 Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

1.10 Financial Instruments

a. Cash and cash equivalents

Cash and cash equivalents include cash at banks and in hand and short term deposits with a maturity date of three months or less.

b. Debtors and creditors

Debtors and creditors receivable or payable within one year of the reporting date are carried at their transaction price. Debtors and creditors that are receivable or payable in more than one year and not subject to a market rate of interest are measured at the present value of the expected future receipts or payment discounted at a market rate of interest.

1.11 Critical accounting judgements and key sources of estimation uncertainty

In the application of the accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factorsthat are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future

2
INCOME FROM CHARITABLE ACTIVITIES
Meetings
Certificate holders' Forum
LASA Forum
Training
Accommodation		 2025
£
93,747
-
-
850
-
94,597		 2024
£
149,930
20,615
1,115
-
1,080
172,740

11

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION

Notes to the accounts

For the year ended 30 June 2025

----- Start of picture text -----
3 INVESTMENT INCOME 2025 2024
£ £
Interest receivable 778 547
4 EXPENDITURE ON CHARITABLE ACTIVITIES Direct Support 2025
YEAR TO 30 JUNE 2025 Costs Costs Total
£ £ £
Expenditure directly allocated to activities
Meetings 77,915 - 77,915
Support costs allocated to activities
Subscriptions and donations - 3,864 3,864
Bursaries and Honoria - 858 858
Administration costs - 28,243 28,243
Bank charges - 1,506 1,506
Website costs - 4,048 4,048
Travelling costs 4,314 4,314
Council expenses - 1,474 1,474
Legal and Professional - 252 252
Accountancy fees - 5,876 5,876
Loss on foreign currency translation - 28 28
Total 77,915 50,463 128,378
Direct Support 2024
YEAR TO 30 JUNE 2024 Costs Costs Total
£ £ £
Expenditure directly allocated to activities
Newsletter 4,238 - 4,238
Certificate holders' forum 3,189 - 3,189
Meetings 95,935 - 95,935
Member publications 3,456 - 3,456
Support costs allocated to activities
Subscriptions and donations - 5,891 5,891
Bursaries and Honoria - 960 960
Administration costs - 25,772 25,772
CPD expenses - 47 47
Bank charges - 2,637 2,637
Website costs - 663 663
Council expenses - 2,625 2,625
Legal and Professional - 395 395
Accountancy fees - 4,405 4,405
Loss on foreign currency translation - 10 10
Total 106,818 43,405 150,223
----- End of picture text -----

Included within support costs are governance costs of £7,601 (2024 - £7,425) All expenditure on charitable activities was unrestricted.

12

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION

Notes to the accounts

For the year ended 30 June 2025

5
NET SURPLUS FOR THE YEAR IS STATED AFTER CHARGING:
Independent Examination fees
Taxation fees
Prior year under-accrual		 2025
Total
£
5,041
450
385		 2024
Total
£
4,405
-
-

6 EMPLOYEES

There were no staff employed by the Association in the year to 30 June 2025 nor 30 June 2024.

7 TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 30 June 2025 nor the year ended 30 June 2024.

During the year, the charitable company paid £940 travel and accomodation expenses (2024: £0) to 2 (2024: 0) trustees.

8 TANGIBLE FIXED ASSETS

Cost or valuation:
At 1 July 2024 and 30 June 2025
Depreciation:
At 30 June 2024 and 30 June 2025
Net Book Value:
At 30 June 2024 and 30 June 2025
9
DEBTORS
Trade debtors
Prepayments		 2025
£
-
6,561
6,561		 Fixtures &
Fittings
£
3,460
3,460
-
2024
£
6,726
58,242
64,968

Apart from prepayments, all debtors are financial instruments and are measured at present value.

13

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION

Notes to the accounts

For the year ended 30 June 2025

10 CREDITORS DUE WITHIN ONE YEAR
Trade creditors
Accruals and deferred income
VAT
Other creditors		 2025
£
2,503
26,272
1,752
36,775
67,302		 2024
£
28,151
29,043
2,126
37,147
96,467

All creditors are financial instruments and are measured at present value.

11 Unrestricted Funds

General fund
General fund		 At
1 July 2024
£
227,687
227,687
At
1 July 2023
£
167,398
167,398		 Incoming
Outgoing
£
£
158,743
(128,378)
158,743
(128,378)
Incoming
Outgoing
£
£
210,512
(150,223)
210,512
(150,223)
Movement in Resources
Movement in Resources		 At
30 June 2025
£
258,052
258,052
At
30 June 2024
£
227,687
227,687

These funds are not by their nature allocated for any other purpose and are utilised for the general day to day tranactions and operations of the charitable company.

12 SHARE CAPITAL

The company has no share capital and is limited by guarantee.

13 RELATED PARTY TRANSACTIONS

During the year, the charitable company had conducted sales of £3,723 with RxCelerate Limited, a company in which a previous trustee (resigned January 2025) had significant control (2024: £15,355). The balance at year end was £nil owed to the charitable company (2024: £618 owed to the charitable company).

During the year, the charitable company had conducted sales of £nil ( 2024: £120) with NC3Rs, and received a donation of £nil (2024: £4,000) from NC3Rs, company in which a trustee has significant influence. No amounts were outstanding at the balance sheet date (2024: £nil).

14

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION DETAILED STATEMENT OF FINANCIAL ACTIVITIES YEAR ENDED 30 JUNE 2025

Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD

LABORATORY ANIMAL SCIENCE ASSOCIATION

Detailed Statement of Financial Activities

For the year ended 30 June 2025

----- Start of picture text -----
Unrestricted funds
2025 2024
£ £
INCOME
Voluntary income
Subscription 29,271 16,509
Sponsorships 33,264 20,716
Donations 833 -
63,368 37,225
Charitable activities
Meetings 93,747 149,930
Certificate holders' Forum - 20,615
LASA Forum - 1,115
Training 850 -
Accommodation - 1,080
94,597 172,740
Investment income
Interest receivable 778 547
Total incoming resources 158,743 210,512
EXPENDITURE
Charitable expenditure
Newsletter - 4,238
Certificate holders' forum - 3,189
Meetings 77,915 95,935
-
Member publications 3,456
77,915 106,818
Support costs
Bursaries and awards 858 960
Subscriptions and donations 3,864 5,891
Administration costs 28,243 25,772
CPD expenses - 47
Bank charges 1,506 2,637
Website costs 4,048 663
-
Travelling 4,314
Council expenses 1,474 2,625
Legal and Professional 252 395
Accountancy fees 5,876 4,405
Loss on foreign currency translation 28 10
50,463 43,405
Total expenditure 128,378 150,223
Surplus for the year 30,365 60,289
----- End of picture text -----